| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Revenue | $549.1M | +2.7% |
| Cost of Revenue | $130.9M | -6.5% |
| Gross Profit | $418.2M | +5.9% |
| R&D Expense | $113.6M | +4.4% |
| SG&A Expense | $128.8M | -19.3% |
| Operating Income | $48.3M | +5937.5% |
| Interest Expense | $6.0M | +0.0% |
| Pre-tax Income | $59.0M | +594.1% |
| Income Tax | $5.8M |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $274.7M | +3.0% |
| Short-term Investments | $85.2M | +19.8% |
| Accounts Receivable | $156.0M | -10.2% |
| Current Assets | $568.2M | -3.9% |
| Total Assets | $1.25B | -3.9% |
| Current Liabilities | $268.1M | -22.1% |
| Long-term Debt | $196.5M | +0.6% |
| Line Item | 2026-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.3M | +204.8% |
| Capital Expenditures | $3.8M | +22.6% |
| Investing Cash Flow | $15.6M | -74.3% |
| Financing Cash Flow | -$58.2M | -1977.4% |
| Free Cash Flow | $46.5M | +247.0% |
| -65.9% |
| Net Income | $53.2M | +167.3% |
| EPS (Basic) | $0.09 | +169.2% |
| EPS (Diluted) | $0.09 | +169.2% |
| Total Liabilities |
| $499.2M |
| -13.3% |
| Stockholders' Equity | $746.0M | +3.6% |